Development of a next-generation wound-healing scaffold integrating decellularized dermis with tailored mesenchymal stromal cell secretomes

Marta Cecilia Tosca(Ospedale Maggiore), Maria Luisa Torre(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Ivana Miletto(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Lorena Segale(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Lorella Giovannelli(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Rossana Rossi(University of Parma), Pierluigi Mauri(Institute of Biomedical Technologies), Dmitry Lim(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Angelo Modena(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Edoardo Bertania(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Dario Di Silvestre, Ilenia Rita Renzulli(University of Pavia), Elia Bari(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Simona Turi(University of Padua), Giovanni Sesana(Ospedale Maggiore)
Journal of Drug Delivery Science and Technology
July 3, 2026
10.1016/j.jddst.2026.108673
Cited by 0

Related Papers

Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue
|Blood|2011|205
Pilot Production of Mesenchymal Stem/Stromal Freeze-Dried Secretome for Cell-Free Regenerative Nanomedicine: A Validated GMP-Compliant Process
|Cells|2018|173
Proteomics of bronchial biopsies: Galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients
|Immunology Letters|2014|101
Caloric Restriction Promotes Immunometabolic Reprogramming Leading to Protection from Tuberculosis
|Cell Metabolism|2021|78
Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months
|Clinical and Translational Allergy|2017|73